Evidence map›Paper›PMID 29359850›Full record

ArticleAngewandte Chemie (International ed. in English)2018

Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins.

Silvia Alonso-de Castro, Aitziber L Cortajarena, Fernando López-Gallego, Luca Salassa

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Modular Fabrication of Bioorthogonal Nanozymes for Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2024
    Review
  9. Article
  10. Article
  11. Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. A Photosensitized Singlet Oxygen (Molecules (Basel, Switzerland) · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Transfer hydrogenation catalysis in cells.RSC chemical biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Silvia Alonso-de CastroCIC biomaGUNE, Paseo de Miramón 182, Donostia, 20014, Spain.
Aitziber L CortajarenaCIC biomaGUNE, Paseo de Miramón 182, Donostia, 20014, Spain.
Fernando López-GallegoCIC biomaGUNE, Paseo de Miramón 182, Donostia, 20014, Spain.
Luca SalassaDonostia International Physics Center, Paseo Manuel de Lardizabal 4, Donostia, 20018, Spain.ORCID 0000-0002-2112-9095
Ikerbasque · ESCIC biomaGUNE · ESFundacion Agencia Aragonesa para la Investigacion y el Desarrollo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in bioorthogonal catalysis promise to deliver new chemical tools for performing chemoselective transformations in complex biological environments. Herein, we report how FAD (flavin adenine dinucleotide), FMN (flavin mononucleotide), and four flavoproteins act as unconventional photocatalysts capable of converting Pt

Indexed as

Antineoplastic AgentsCatalysisCoordination ComplexesFlavin-Adenine DinucleotideFlavin MononucleotideFlavoproteinsLightModels, MolecularMolecular StructurePhotochemical ProcessesPlatinumRutheniumAntineoplastic AgentsCoordination ComplexesFlavin-Adenine DinucleotideFlavin MononucleotideFlavoproteinsPlatinumRutheniumbioorthogonal chemistryflavoproteinsmetal-based prodrugsphotocatalysisphotochemotherapy

Identifiers

PMID29359850
PMCPMC5887934
OpenAlexW2791347655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.